Henry Schein (NASDAQ:HSIC) and Pro-Dex (NASDAQ:PDEX) Head-To-Head Analysis

Henry Schein (NASDAQ:HSIC) and Pro-Dex (NASDAQ:PDEX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership.

Institutional & Insider Ownership

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk & Volatility

Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500.

Profitability

This table compares Henry Schein and Pro-Dex’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.05%	14.36%	5.52%
Pro-Dex	13.48%	26.67%	14.95%

Analyst Recommendations

This is a breakdown of recent ratings for Henry Schein and Pro-Dex, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	0	8	5	0	2.38
Pro-Dex	0	1	1	0	2.50

Henry Schein presently has a consensus target price of $76.67, indicating a potential upside of 21.31%. Pro-Dex has a consensus target price of $56.00, indicating a potential upside of 54.53%. Given Pro-Dex’s stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Henry Schein.

Earnings & Valuation

This table compares Henry Schein and Pro-Dex”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$12.77 billion	0.60	$390.00 million	$3.10	20.39
Pro-Dex	$66.59 million	1.78	$8.98 million	$2.70	13.42

Henry Schein has higher revenue and earnings than Pro-Dex. Pro-Dex is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

About Pro-Dex

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.